The global Biopharmaceutical CMO and CRO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO and CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO and CRO.

Report Scope

The Biopharmaceutical CMO and CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical CMO and CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical CMO and CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical CMO and CRO Market Report

Report Metric	Details
Report Name	Biopharmaceutical CMO and CRO Market
CAGR	5%
Segment by Type	Contract Manufacturing Contract Research
Segment by Application	Biologics Manuefacturing Biosimilars Manuefacturing Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG, Rentschler Biopharma SE, Samsung BioLogics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CMO and CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical CMO and CRO Market report?

Ans: The main players in the Biopharmaceutical CMO and CRO Market are AGC Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Inno Bio Ventures Sdn Bhd, JRS PHARMA, Lonza, PRA Health Sciences, Inc., ProBioGen AG, Rentschler Biopharma SE, Samsung BioLogics

What are the Application segmentation covered in the Biopharmaceutical CMO and CRO Market report?

Ans: The Applications covered in the Biopharmaceutical CMO and CRO Market report are Biologics Manuefacturing, Biosimilars Manuefacturing, Other

What are the Type segmentation covered in the Biopharmaceutical CMO and CRO Market report?

Ans: The Types covered in the Biopharmaceutical CMO and CRO Market report are Contract Manufacturing, Contract Research

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Contract Manufacturing

1.2.3 Contract Research

1.3 Market by Application

1.3.1 Global Biopharmaceutical CMO and CRO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Biologics Manuefacturing

1.3.3 Biosimilars Manuefacturing

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical CMO and CRO Market Perspective (2019-2030)

2.2 Biopharmaceutical CMO and CRO Growth Trends by Region

2.2.1 Global Biopharmaceutical CMO and CRO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biopharmaceutical CMO and CRO Historic Market Size by Region (2019-2024)

2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2025-2030)

2.3 Biopharmaceutical CMO and CRO Market Dynamics

2.3.1 Biopharmaceutical CMO and CRO Industry Trends

2.3.2 Biopharmaceutical CMO and CRO Market Drivers

2.3.3 Biopharmaceutical CMO and CRO Market Challenges

2.3.4 Biopharmaceutical CMO and CRO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue

3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2019-2024)

3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2019-2024)

3.2 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceutical CMO and CRO Revenue

3.4 Global Biopharmaceutical CMO and CRO Market Concentration Ratio

3.4.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2023

3.5 Biopharmaceutical CMO and CRO Key Players Head office and Area Served

3.6 Key Players Biopharmaceutical CMO and CRO Product Solution and Service

3.7 Date of Enter into Biopharmaceutical CMO and CRO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical CMO and CRO Breakdown Data by Type

4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2019-2024)

4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2025-2030)

5 Biopharmaceutical CMO and CRO Breakdown Data by Application

5.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Application (2019-2024)

5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biopharmaceutical CMO and CRO Market Size (2019-2030)

6.2 North America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biopharmaceutical CMO and CRO Market Size by Country (2019-2024)

6.4 North America Biopharmaceutical CMO and CRO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical CMO and CRO Market Size (2019-2030)

7.2 Europe Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biopharmaceutical CMO and CRO Market Size by Country (2019-2024)

7.4 Europe Biopharmaceutical CMO and CRO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size (2019-2030)

8.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2019-2024)

8.4 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical CMO and CRO Market Size (2019-2030)

9.2 Latin America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2019-2024)

9.4 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size (2019-2030)

10.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2019-2024)

10.4 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AGC Biologics

11.1.1 AGC Biologics Company Detail

11.1.2 AGC Biologics Business Overview

11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction

11.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.1.5 AGC Biologics Recent Development

11.2 Boehringer Ingelheim International GmbH

11.2.1 Boehringer Ingelheim International GmbH Company Detail

11.2.2 Boehringer Ingelheim International GmbH Business Overview

11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction

11.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.2.5 Boehringer Ingelheim International GmbH Recent Development

11.3 FUJIFILM Diosynth Biotechnologies

11.3.1 FUJIFILM Diosynth Biotechnologies Company Detail

11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction

11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.4 Inno Bio Ventures Sdn Bhd

11.4.1 Inno Bio Ventures Sdn Bhd Company Detail

11.4.2 Inno Bio Ventures Sdn Bhd Business Overview

11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction

11.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.4.5 Inno Bio Ventures Sdn Bhd Recent Development

11.5 JRS PHARMA

11.5.1 JRS PHARMA Company Detail

11.5.2 JRS PHARMA Business Overview

11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction

11.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.5.5 JRS PHARMA Recent Development

11.6 Lonza

11.6.1 Lonza Company Detail

11.6.2 Lonza Business Overview

11.6.3 Lonza Biopharmaceutical CMO and CRO Introduction

11.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.6.5 Lonza Recent Development

11.7 PRA Health Sciences, Inc.

11.7.1 PRA Health Sciences, Inc. Company Detail

11.7.2 PRA Health Sciences, Inc. Business Overview

11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction

11.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.7.5 PRA Health Sciences, Inc. Recent Development

11.8 ProBioGen AG

11.8.1 ProBioGen AG Company Detail

11.8.2 ProBioGen AG Business Overview

11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction

11.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.8.5 ProBioGen AG Recent Development

11.9 Rentschler Biopharma SE

11.9.1 Rentschler Biopharma SE Company Detail

11.9.2 Rentschler Biopharma SE Business Overview

11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction

11.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.9.5 Rentschler Biopharma SE Recent Development

11.10 Samsung BioLogics

11.10.1 Samsung BioLogics Company Detail

11.10.2 Samsung BioLogics Business Overview

11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction

11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2019-2024)

11.10.5 Samsung BioLogics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

FUJIFILM Diosynth Biotechnologies

Inno Bio Ventures Sdn Bhd

JRS Pharma

PRA Health Sciences, Inc.

Rentschler Biopharma SE

List of Tables

Table 1. Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Contract Manufacturing

Table 3. Key Players of Contract Research

Table 4. Global Biopharmaceutical CMO and CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Biopharmaceutical CMO and CRO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Biopharmaceutical CMO and CRO Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Biopharmaceutical CMO and CRO Market Share by Region (2019-2024)

Table 8. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Biopharmaceutical CMO and CRO Market Share by Region (2025-2030)

Table 10. Biopharmaceutical CMO and CRO Market Trends

Table 11. Biopharmaceutical CMO and CRO Market Drivers

Table 12. Biopharmaceutical CMO and CRO Market Challenges

Table 13. Biopharmaceutical CMO and CRO Market Restraints

Table 14. Global Biopharmaceutical CMO and CRO Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Biopharmaceutical CMO and CRO Market Share by Players (2019-2024)

Table 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2023)

Table 17. Ranking of Global Top Biopharmaceutical CMO and CRO Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO and CRO Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Biopharmaceutical CMO and CRO Product Solution and Service

Table 21. Date of Enter into Biopharmaceutical CMO and CRO Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2019-2024)

Table 25. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2025-2030)

Table 27. Global Biopharmaceutical CMO and CRO Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2019-2024)

Table 29. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2025-2030)

Table 31. North America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Biopharmaceutical CMO and CRO Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Biopharmaceutical CMO and CRO Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Biopharmaceutical CMO and CRO Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Biopharmaceutical CMO and CRO Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Biopharmaceutical CMO and CRO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2025-2030) & (US$ Million)

Table 46. AGC Biologics Company Detail

Table 47. AGC Biologics Business Overview

Table 48. AGC Biologics Biopharmaceutical CMO and CRO Product

Table 49. AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 50. AGC Biologics Recent Development

Table 51. Boehringer Ingelheim International GmbH Company Detail

Table 52. Boehringer Ingelheim International GmbH Business Overview

Table 53. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product

Table 54. Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 55. Boehringer Ingelheim International GmbH Recent Development

Table 56. FUJIFILM Diosynth Biotechnologies Company Detail

Table 57. FUJIFILM Diosynth Biotechnologies Business Overview

Table 58. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product

Table 59. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 60. FUJIFILM Diosynth Biotechnologies Recent Development

Table 61. Inno Bio Ventures Sdn Bhd Company Detail

Table 62. Inno Bio Ventures Sdn Bhd Business Overview

Table 63. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product

Table 64. Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 65. Inno Bio Ventures Sdn Bhd Recent Development

Table 66. JRS PHARMA Company Detail

Table 67. JRS PHARMA Business Overview

Table 68. JRS PHARMA Biopharmaceutical CMO and CRO Product

Table 69. JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 70. JRS PHARMA Recent Development

Table 71. Lonza Company Detail

Table 72. Lonza Business Overview

Table 73. Lonza Biopharmaceutical CMO and CRO Product

Table 74. Lonza Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 75. Lonza Recent Development

Table 76. PRA Health Sciences, Inc. Company Detail

Table 77. PRA Health Sciences, Inc. Business Overview

Table 78. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product

Table 79. PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 80. PRA Health Sciences, Inc. Recent Development

Table 81. ProBioGen AG Company Detail

Table 82. ProBioGen AG Business Overview

Table 83. ProBioGen AG Biopharmaceutical CMO and CRO Product

Table 84. ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 85. ProBioGen AG Recent Development

Table 86. Rentschler Biopharma SE Company Detail

Table 87. Rentschler Biopharma SE Business Overview

Table 88. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product

Table 89. Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 90. Rentschler Biopharma SE Recent Development

Table 91. Samsung BioLogics Company Detail

Table 92. Samsung BioLogics Business Overview

Table 93. Samsung BioLogics Biopharmaceutical CMO and CRO Product

Table 94. Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2019-2024) & (US$ Million)

Table 95. Samsung BioLogics Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceutical CMO and CRO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biopharmaceutical CMO and CRO Market Share by Type: 2023 VS 2030

Figure 3. Contract Manufacturing Features

Figure 4. Contract Research Features

Figure 5. Global Biopharmaceutical CMO and CRO Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Biopharmaceutical CMO and CRO Market Share by Application: 2023 VS 2030

Figure 7. Biologics Manuefacturing Case Studies

Figure 8. Biosimilars Manuefacturing Case Studies

Figure 9. Other Case Studies

Figure 10. Biopharmaceutical CMO and CRO Report Years Considered

Figure 11. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Biopharmaceutical CMO and CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Biopharmaceutical CMO and CRO Market Share by Region: 2023 VS 2030

Figure 14. Global Biopharmaceutical CMO and CRO Market Share by Players in 2023

Figure 15. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO and CRO Revenue in 2023

Figure 17. North America Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Biopharmaceutical CMO and CRO Market Share by Country (2019-2030)

Figure 19. United States Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Biopharmaceutical CMO and CRO Market Share by Country (2019-2030)

Figure 23. Germany Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Region (2019-2030)

Figure 31. China Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Biopharmaceutical CMO and CRO Market Share by Country (2019-2030)

Figure 39. Mexico Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Country (2019-2030)

Figure 43. Turkey Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Biopharmaceutical CMO and CRO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 46. Boehringer Ingelheim International GmbH Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 47. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 48. Inno Bio Ventures Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 49. JRS PHARMA Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 50. Lonza Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 51. PRA Health Sciences, Inc. Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 52. ProBioGen AG Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 53. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 54. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

CDMO Market

120 Pages

Type: Report

Code: QYRE-Auto-5Q14261

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Silica - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-38W13955

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Pharma Grade Sodium Hydroxide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-30U13946

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Sorbitol Liquid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-23N13862

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Biopharmaceutical CMO and CRO Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-36L1348

Global Biopharmaceutical CMO and CRO Market Research Report 2024

FEATURED COMPANIES

Biopharmaceutical CMO and CRO Market Size

Biopharmaceutical CMO and CRO Market

Report Scope

Scope of Biopharmaceutical CMO and CRO Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Biopharmaceutical CMO and CRO Market report?

What are the Application segmentation covered in the Biopharmaceutical CMO and CRO Market report?

What are the Type segmentation covered in the Biopharmaceutical CMO and CRO Market report?

FEATURED COMPANIES

RELATED REPORTS